Biotech Values

[Biowatch]

RVNC 6 month chart is dire, long term chart shows that it’s a roller coaster barely bouncing off record lows.

I’m sorry, or perhaps I’m glad, if I’m just an indicator of the low, but I’ve never seen a biotech stock do this after approvals.

Yes, maybe after they get the J code and widespread insurance coverage for CD things will turn around, but they could have given investors a heads up about this aspect long before now.

RVNC is apparently slow-walking the CD rollout so the full-scale launch comes after Medicare issues a permanent "J" code, which is expected to happen in 1H24, according to the 3Q23 CC.